Q32 Bio Inc. (FIXX) Return on equity 2018–2025
Q32 Bio Inc. (FIXX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
71.0%FY2025 · since FY2018: -28.3% → 71.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 71.0% | +912.1 pp |
| FY2024 | -841.1% | — |
| FY2021 | -56.4% | +9.2 pp |
| FY2020 | -65.7% | -25.5 pp |
| FY2019 | -40.2% | -11.9 pp |
| FY2018 | -28.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice